Core Insights - Supernus Pharmaceuticals, Inc. is participating in multiple investor conferences in September 2025, showcasing its focus on central nervous system (CNS) diseases [1][2][3] Conference Details - The company will present at the Cantor Global Healthcare Conference on September 3, 2025, at 8:00 a.m. ET in New York [1] - The Wells Fargo Healthcare Conference is scheduled for September 4, 2025, at 8:45 a.m. ET in Everett, MA [2] - The TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit will take place virtually on September 18, 2025, at 10:40 a.m. ET [3] Webcast Information - A live audio webcast of the presentations will be available on the Supernus Pharmaceuticals website, with archived replays accessible for 60 days post-conference [4] Company Overview - Supernus Pharmaceuticals specializes in developing and commercializing products for CNS diseases, with a diverse portfolio that includes treatments for ADHD, Parkinson's disease, postpartum depression, epilepsy, migraine, cervical dystonia, and chronic sialorrhea [5][6]